111 related articles for article (PubMed ID: 37633130)
1. Sociodemographic profiles and determinants of relapse risks among people with substance use disorders in the Philippines: A survey in community and residential care settings.
Harada T; Kanamori S; Baba T; Takano A; Nomura K; Villaroman A; Rey FI; Peralta J; Shirasaka T
Drug Alcohol Depend; 2023 Oct; 251():110924. PubMed ID: 37633130
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of Tagalog versions of the Drug Abuse Screening Test-20 (DAST-20) and Stimulant Relapse Risk Scale (SRRS) for drug users in the Philippines.
Harada T; Nomura K; Baba T; Shirasaka T; Takano A; Kanamori S
PLoS One; 2023; 18(1):e0280047. PubMed ID: 36607996
[TBL] [Abstract][Full Text] [Related]
3. The Manila Declaration on the Drug Problem in the Philippines.
Simbulan N; Estacio L; Dioquino-Maligaso C; Herbosa T; Withers M
Ann Glob Health; 2019 Mar; 85(1):. PubMed ID: 30873786
[TBL] [Abstract][Full Text] [Related]
4. Perceived unmet need and barriers to care amongst street-involved people who use illicit drugs.
Hyshka E; Anderson JT; Wild TC
Drug Alcohol Rev; 2017 May; 36(3):295-304. PubMed ID: 27242102
[TBL] [Abstract][Full Text] [Related]
5. The Philippines' antidrug campaign: Spatial and temporal patterns of killings linked to drugs.
Atun JML; Mendoza RU; David CC; Cossid RPN; Soriano CRR
Int J Drug Policy; 2019 Nov; 73():100-111. PubMed ID: 31446164
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial treatment for incarcerated methamphetamine users: the Philippines experience.
Hechanova MRM; Reyes JC; Acosta AC; Tuliao AP
Int J Prison Health; 2020 Aug; 16(4):343-358. PubMed ID: 33634665
[TBL] [Abstract][Full Text] [Related]
7. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
[TBL] [Abstract][Full Text] [Related]
8. Religious institutions as a link to substance use treatment: Characterizing the potential service population through national survey data.
Heikkila HD; Edens EL; Stefanovics EA; Rhee TG; Rosenheck RA
Subst Abus; 2022; 43(1):699-707. PubMed ID: 35099366
[No Abstract] [Full Text] [Related]
9. Screening and brief intervention for alcohol and other abuse.
Harris SK; Louis-Jacques J; Knight JR
Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
[TBL] [Abstract][Full Text] [Related]
10. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment.
Kelly PJ; Kyngdon F; Ingram I; Deane FP; Baker AL; Osborne BA
Drug Alcohol Rev; 2018 Jan; 37(1):79-86. PubMed ID: 28480521
[TBL] [Abstract][Full Text] [Related]
11. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
12. Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia.
Tanguay P; Kamarulzaman A; Aramrattana A; Wodak A; Thomson N; Ali R; Vumbaca G; Lai G; Chabungbam A
Harm Reduct J; 2015 Oct; 12():31. PubMed ID: 26470779
[TBL] [Abstract][Full Text] [Related]
13. Probability and predictors of treatment-seeking for substance use disorders in the U.S.
Blanco C; Iza M; Rodríguez-Fernández JM; Baca-García E; Wang S; Olfson M
Drug Alcohol Depend; 2015 Apr; 149():136-44. PubMed ID: 25725934
[TBL] [Abstract][Full Text] [Related]
14. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
[TBL] [Abstract][Full Text] [Related]
15. Assessing service and treatment needs of young people who use illicit and non-medical prescription drugs living in Northern Ontario, Canada.
Varatharajan T; Sabioni P; Russell C; Henderson J; Fischer B; Miles S; Rehm J
F1000Res; 2018; 7():1644. PubMed ID: 32117563
[No Abstract] [Full Text] [Related]
16. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
[TBL] [Abstract][Full Text] [Related]
17. The ability of single screening questions for unhealthy alcohol and other drug use to identify substance dependence in primary care.
Saitz R; Cheng DM; Allensworth-Davies D; Winter MR; Smith PC
J Stud Alcohol Drugs; 2014 Jan; 75(1):153-7. PubMed ID: 24411807
[TBL] [Abstract][Full Text] [Related]
18. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Lynskey MT; Agrawal A
Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.
Hunt GE; Large MM; Cleary M; Lai HMX; Saunders JB
Drug Alcohol Depend; 2018 Oct; 191():234-258. PubMed ID: 30153606
[TBL] [Abstract][Full Text] [Related]
20. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
Newcombe DA; Humeniuk RE; Ali R
Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
